Client Result
Carlyle and SK Capital Complete Acquisition of bluebird bio
2 minute read | June.12.2025

2 minute read | June.12.2025
1 minute read | April.25.2025
1 minute read | April.15.2025
1 minute read | May.06.2024
Meta prevails in important test of corporate law protections, earning Orrick recognition in Litigators of the Week.
1 minute read | May.02.2023
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
September.29.2021